PD-033 Right-sided colon cancer is associated with increased frequency of KRAS mutation and with a poor outcome in patients with metastatic disease treated in the first line with bevacizumab and chemotherapy

Autor: Ostrizkova, L., Petruželka, L., Hejduk, K., Zdražilová-Dubská, L., Vocka, M., Brancikova, D., Bencsiková, B., Vyzula, R., Obermannová, R.
Zdroj: In Annals of Oncology June 2016 27 Supplement 2:ii114-ii114
Databáze: ScienceDirect